|
1
|
O’Kane JW, Hutchinson E, Atley LM and Eyre
DR: Sport-related differences in biomarkers of bone resorption and
cartilage degradation in endurance athletes. Osteoarthritis
Cartilage. 14:71–76. 2006.PubMed/NCBI
|
|
2
|
Roos H, Dahlberg L, Hoerrner LA, Lark MW,
Thonar EJ, Shinmei M, Lindqvist U and Lohmander LS: Markers of
cartilage matrix metabolism in human joint fluid and serum: the
effect of exercise. Osteoarthritis Cartilage. 3:7–14. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qi C and Changlin H: Effects of moving
training on histology and biomarkers levels of articular cartilage.
J Surg Res. 135:352–363. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qi C, Changlin H and Zefeng H: Matrix
metalloproteinases and inhibitor in knee synovial fluid as
cartilage biomarkers in rabbits: the effect of high-intensity
jumping exercise. J Surg Res. 140:149–157. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim HJ, Lee YH and Kim CK: Biomarkers of
muscle and cartilage damage and inflammation during a 200 km run.
Eur J Appl Physiol. 99:443–447. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Buckwalter JA and Lane NE: Does
participation in sports cause osteoarthritis? Iowa Orthop J.
17:80–89. 1997.PubMed/NCBI
|
|
7
|
Buckwalter JA and Lane NE: Athletics and
osteoarthritis. Am J Sports Med. 25:873–881. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Creighton DL, Morgan AL, Boardley D and
Brolinson PG: Weight-bearing exercise and markers of bone turnover
in female athletes. J Appl Physiol. 90:565–570. 2001.PubMed/NCBI
|
|
9
|
Garnero P, Rousseau JC and Delmas PD:
Molecular basis and clinical use of biochemical markers of bone,
cartilage and synovium in joint diseases. Arthritis Rheum.
43:953–968. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garnero P, Piperno M, Gineyts E, Christgau
S, Delmas PD and Vignon E: Cross sectional evaluation of
biochemical markers of bone, cartilage and synovial tissue
metabolism in patients with knee osteoarthritis: relations with
disease activity and joint damage. Ann Rheum Dis. 60:619–626. 2001.
View Article : Google Scholar
|
|
11
|
Poole AR: Biochemical/immunochemical
biomarkers of osteoarthritis: utility for prediction of incident or
progressive osteoarthritis. Rheum Dis Clin North Am. 29:803–818.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Christgau S, Garnero P, Fledelius C, Moniz
C, Ensig M, Gineyts E, Rosenquist C and Qvist P: Collagen type II
C-telopeptide fragments as an index of cartilage degradation. Bone.
29:209–215. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Poole AR, Ionescu M, Fitzcharles MA and
Billinghurst RC: The assessment of cartilage degradation in vivo:
development of an immunoassay for the measurement in body fluids of
type II collagen cleaved by collagenases. J Immunol Methods.
294:145–153. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shinmei M, Ito K, Matsuyama S, Yoshihara Y
and Matsuzawa K: Joint fluid carboxy-terminal type II procollagen
peptide as a marker of cartilage collagen biosynthesis.
Osteoarthritis Cartilage. 1:121–128. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Garnero P and Delmas PD: Biomarkers in
osteoarthritis. Curr Opin Rheumatol. 15:641–646. 2003. View Article : Google Scholar
|
|
16
|
Rousseau JC and Delmas PD: Biological
markers in osteoarthritis. Nat Clin Pract Rheumatol. 3:346–356.
2007. View Article : Google Scholar
|
|
17
|
Warner SE, Shaw JM and Dalsky GP: Bone
mineral density of competitive male mountain and road cyclists.
Bone. 30:281–286. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smathers AM, Bemben MG and Bemben DA: Bone
density comparisons in male competitive road cyclists and untrained
controls. Med Sci Sports Exerc. 41:290–296. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stewart AD and Hannan J: Total and
regional bone density in male runners, cyclists and controls. Med
Sci Sports Exerc. 32:1373–1377. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nichols JF, Palmer JE and Levy SS: Low
bone mineral density in highly trained male master cyclists.
Osteoporos Int. 14:644–649. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rector RS, Rogers R, Ruebel M and Hinton
PS: Participation in road cycling vs running is associated with
lower bone mineral density in men. Metabolism. 57:226–232. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang SH, Johnson K and Pipe AL: The use
of dietary supplements and medications by Canadian athletes at the
Atlanta and Sydney Olympic Games. Clin J Sport Med. 16:27–33. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Froiland K, Koszewski W, Hingst J and
Kopecky L: Nutritional supplement use among college athletes and
their sources of information. Int J Sport Nutr Exerc Metab.
14:104–120. 2004.PubMed/NCBI
|
|
24
|
Schwenk TL and Costley CD: When food
becomes a drug: nonanabolic nutritional supplement use in athletes.
Am J Sports Med. 30:907–916. 2002.PubMed/NCBI
|
|
25
|
Dascombea BJ, Karunaratna M, Cartoon J,
Fergie B and Goodmana C: Nutritional supplementation habits and
perceptions of elite athletes within a state-based sporting
institute. J Sci Med Sport. 13:274–280. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gorsline RT and Kaeding CC: The use of
NSAIDs and nutritional supplements in athletes with osteoarthritis:
prevalence, benefits and consequences. Clin Sports Med. 24:71–82.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ostojic SM, Arsic M, Prodanovic S, Vukovic
J and Zlatanovic M: Glucosamine administration in athletes: effects
on recovery of acute knee injury. Res Sports Med. 15:113–124. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
McAlindon TE, Lavalley MP, Gulin JP and
Felson DT: Glucosamine and chondroitin for treatment of
osteoarthritis: a systematic quality assessment and meta-analysis.
JAMA. 283:1469–1475. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Reginster JY, Deroisy R, Rovati LC, Lee
RL, Lejeune E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE and
Gossett C: Long-term effects of glucosamine sulphate on
osteoarthritis progression: a randomized, placebo-controlled
clinical trial. Lancet. 357:251–256. 2001. View Article : Google Scholar
|
|
30
|
Pavelká K, Gatterová J, Olejarová M,
Machacek S, Giacovelli G and Rovati LC: Glucosamine sulfate use and
delay of progression of knee osteoarthritis: a 3-year, randomized,
placebo-controlled, double-blind study. Arch Intern Med.
162:2113–2123. 2002.PubMed/NCBI
|
|
31
|
Igarashi M, Kaga I, Takamori Y, Sakamoto
K, Miyazawa K and Nagaoka I: Effects of glucosamine derivatives and
uronic acids on the production of glycosaminoglycans by human
synovial cells and chondrocytes. Int J Mol Med. 27:821–827.
2011.PubMed/NCBI
|
|
32
|
Nakamura H, Shibakawa A, Tanaka M, Kato T
and Nishioka K: Effects of glucosamine hydrochloride on the
production of prostaglandin E2, nitric oxide and metalloproteases
by chondrocytes and synoviocytes in osteoarthritis. Clin Exp
Rheumatol. 22:293–299. 2004.PubMed/NCBI
|
|
33
|
Derfoul A, Miyoshi AD, Freeman DE and Tuan
RS: Glucosamine promotes chondrogenic phenotype in both
chondrocytes and mesenchymal stem cells and inhibits MMP-13
expression and matrix degradation. Osteoarthr Cartil. 15:646–655.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yoshimura M, Sakamoto K, Tsuruta A,
Yamamoto T, Ishida K, Yamaguchi H and Nagaoka I: Evaluation of the
effect of glucosamine administration on biomarkers for cartilage
and bone metabolism in soccer players. Int J Mol Med. 24:487–494.
2009.PubMed/NCBI
|
|
35
|
Cahue S, Sharma L, Dunlop D, Ionescu M,
Song J, Lobanok T, King L and Poole AR: The ratio of type II
collagen breakdown to synthesis and its relationship with the
progression of knee osteoarthritis. Osteoarthritis Cartilage.
15:819–823. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sharif M, Kirwan J, Charni N, Sandell LJ,
Whittles C and Garnero P: A 5-yr longitudinal study of type IIA
collagen synthesis and total type II collagen degradation in
patients with knee osteoarthritis - association with disease
progression. Rheumatol. 46:938–943. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Igarashi M, Sakamoto K and Nagaoka I:
Effect of glucosamine, a therapeutic agent for osteoarthritis, on
osteoblastic cell differentiation. Int J Mol Med. 28:373–379.
2011.PubMed/NCBI
|
|
38
|
Wang SX, Laverty S, Dumitriu M, Plaas A
and Grynpas MD: The effects of glucosamine hydrochloride on
subchondral bone changes in any animal model of osteoarthritis.
Arthritis Rheum. 56:1537–1548. 2007. View Article : Google Scholar : PubMed/NCBI
|
